USX:MDXG - MiMedx Group Inc MiMedx Group Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 30 Apr 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 7.61    -0.01 (-0.13%)

27 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Mr. William F. Hulse IV

IPO: 2007-08-22

Headquarters: US

Employees: 895

Homepage

Description

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server Fundamental

About · FAQs · StocksCafe © 2024 · Privacy · Terms